Proactive Therapeutic Drug MONiToring to Guide Suppressive Antibiotic Therapy with DALBAvaNcin ( > 12 weeks) in Osteoarticular Infections (MONTALBANO)Chiara Mariani, Dario Cattaneo, Matteo Passerini et al.|Journal of Bone and Joint Infection|2025Cited by 2
STELO: a new tool for family physicians for the correct identification of inherited cancer syndromesChiara Mariani, Maria Grazia Tibiletti, Ileana Carnevali et al.|Family Practice|2019Cited by 1
A THERAPEUTIC DRUG-MONITORING APPROACH FOR DALBAVANCIN (MONTALBANO)Simona Landonio, Andrea Gori, Lucia Galli et al.|Orthopaedic Proceedings|2024Cited by 0
A real-world implementation study of a TDM-guided dalbavancin model for bone and joint infections (101 Dalbatians)Andrea Rabbione, Matteo Passerini, F Petri et al.|JAC-Antimicrobial Resistance|2026Cited by 0